NeuroOne Medical reports patient surpasses one year milestone of seizure freedom

NeuroOne Medical (NMTC) Technologies announced that Clara – an early patient treated with the Company’s patented OneRF Ablation System – has successfully surpassed the one year milestone of being seizure free. “This milestone further validates the intended benefits of our OneRF platform. Our next step is to leverage the technology for other applications, including our OneRF Trigeminal Nerve Ablation System to treat facial pain, for which we filed a 510(k) submission to the FDA in April 2025,” said Dave Rosa, CEO of NeuroOne.